Goldman Sachs Group Inc Tonix Pharmaceuticals Holding Corp. Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 14, 2024
BUY
$0.53 - $1.9 $12,344 - $44,254
23,292 Added 213.88%
34,182 $18,000
Q3 2022

Nov 10, 2022
BUY
$0.53 - $1.9 $12,344 - $44,254
23,292 Added 213.88%
34,182 $18,000
Q2 2022

May 14, 2024
BUY
$1.58 - $7.36 $17,206 - $80,150
10,890 New
10,890 $17,000
Q2 2022

Aug 15, 2022
BUY
$1.58 - $7.36 $17,206 - $80,150
10,890 New
10,890 $17,000

About Tonix Pharmaceuticals Holding Corp.

TNXP Quotes by TradingView
  • Ticker TNXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,752,700
  • Market Cap $7.25M
  • Description
  • Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...
More about TNXP
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email